Methylphenidate normalizes resting-state brain dysfunction in boys with attention deficit hyperactivity disorder

Neuropsychopharmacology

Volumn 38, Issue 7, 2013, Pages 1287-1295

  An, Li ^a,b   Cao, Xiao Hua ^a,b   Cao, Qing Jiu ^a,b   Sun, Li ^a,b   Yang, Li ^a,b   Zou, Qi Hong ^b   Katya, Rubia ^c   Zang, Yu Feng ^d,e   Wang, Yu Feng ^a,b  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d HANGZHOU NORMAL UNIVERSITY   (China)

^e BEIJING NORMAL UNIVERSITY   (China)

Author keywords

attention deficit hyperactivity disorder (ADHD); functional magnetic resonance imaging (fMRI); methylphenidate hydrochloride (MPH); regional homogeneity (ReHo); resting state; treatment response prediction

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DYSFUNCTION; CEREBELLUM VERMIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; PARIETAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-OVER STUDIES; FUNCTIONAL NEUROIMAGING; HUMANS; MALE; METHYLPHENIDATE; REST;

EID: 84878583977     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.27     Document Type: Article

References (55)

1. Anderson CM, Polcari A, Lowen SB, Renshaw PF, Teicher MH (2002). Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD. Am J Psychiatry 159: 1322-1328.
2. Arnsten AF (2009a). The emerging neurobiology of attention deficit hyperactivity disorder: the key role of the prefrontal association cortex. J Pediatr 154: 43.
3. Arnsten AF (2009b). Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci 10: 410-422.
4. Arnsten AF, Rubia K (2012). Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry 51: 356-367.
5. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B et al (2006). Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60: 1111-1120.
6. Biederman J, Faraone SV (2005). Attention-deficit hyperactivity disorder. Lancet 366: 237-248.
7. Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M (1995). Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34: 1025-1032.
8. Cao Q, Zang Y, Sun L, Sui M, Long X, Zou Q et al (2006). Abnormal neural activity in children with attention deficit hyperactivity disorder: a resting-state functional magnetic resonance imaging study. Neuroreport 17: 1033-1036.
9. Chambers CD, Garavan H, Bellgrove MA (2009). Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neurosci Biobehav Rev 33: 631-646.
10. Cho SC, Hwang JW, Kim BN, Lee HY, Kim HW, Lee JS et al (2007). The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders. J Psychiatr Res 41: 459-465.
11. Culham JC, Kanwisher NG (2001). Neuroimaging of cognitive functions in human parietal cortex. Curr Opin Neurobiol 11: 157-163.
12. Dennis M, Francis DJ, Cirino PT, Schachar R, Barnes MA, Fletcher JM (2009). Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders. J Int Neuropsychol Soc 15: 331-343.
13. Dias R, Robbins TW, Roberts AC (1996). Dissociation in prefrontal cortex of affective and attentional shifts. Nature 380: 69-72.
14. Dickstein SG, Bannon K, Castellanos FX, Milham MP (2006). The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry 47: 1051-1062.
15. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998). ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretations. Guilford: New Yor.k.
16. Durston S, van Belle J, de Zeeuw P (2011). Differentiating frontostriatal and fronto-cerebellar circuits in attention-deficit/ hyperactivity disorder. Biol Psychiatry 69: 1178-1184.
17. Epstein JN, Casey BJ, Tonev ST, Davidson MC, Reiss AL, Garrett A et al (2007). ADHD-and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD. J Child Psychol Psychiatry 48: 899-913.
18. Gong YX, Cai TS (1993). Manual of Chinese revised Wechsler Intelligence Scale for Children. Hunan Atlas Publishing House: Changsh.a.
19. Goyette CH, Conners CK, Ulrich RF (1978). Normative data on revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol 6: 221-236.
20. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P et al (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36: 980-988.
21. Kendall M, Gibbons J (1990). Rank Correlation Methods. Oxford University Press: Oxfor.d.
22. Kim BN, Lee JS, Cho SC, Lee DS (2001). Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/ hyperactivity disorder. Yonsei Med J 42: 19-29.
23. Konrad K, Eickhoff SB (2010). Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder. Hum Brain Mapp 31: 904-916.
24. Konrad K, Neufang S, Fink GR, Herpertz-Dahlmann B (2007). Long-term effects of methylphenidate on neural networks associated with executive attention in children with ADHD: results from a longitudinal functional MRI study. J Am Acad Child Adolesc Psychiatry 46: 1633-1641.
25. Kuczenski R, Segal DS (1997). Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68: 2032-2037.
26. Kuczenski R, Segal DS (2002). Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22: 7264-7271.
27. Kuczenski R, Segal DS (2005). Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry 57: 1391-1396.
28. Lee JS, Kim BN, Kang E, Lee DS, Kim YK, Chung JK et al (2005). Regional cerebral blood flow in children with attention deficit hyperactivity disorder: comparison before and after methylphenidate treatment. Hum Brain Mapp 24: 157-164.
29. Leopold DA, Murayama Y, Logothetis NK (2003). Very slow activity fluctuations in monkey visual cortex: implications for functional brain imaging. Cereb Cortex 13: 422-433.
30. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A (2001). Neurophysiological investigation of the basis of the fMRI signal. Nature 412: 150-157.
31. Lou HC, Henriksen L, Bruhn P (1984). Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol 41: 825-829.
32. Lou HC, Henriksen L, Bruhn P, Borner H, Nielsen JB (1989). Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 46: 48-52.
33. Makris N, Buka SL, Biederman J, Papadimitriou GM, Hodge SM, Valera EM et al (2008). Attention and executive systems abnormalities in adults with childhood ADHD: A DT-MRI study of connections. Cereb Cortex 18: 1210-1220.
34. Mankinen K, Long XY, Paakki JJ, Harila M, Rytky S, Tervonen O et al (2011). Alterations in regional homogeneity of baseline brain activity in pediatric temporal lobe epilepsy. Brain Res 1373: 221-229.
35. Miller GA, Chapman JP (2001). Misunderstanding analysis of covariance. J Abnorm Psychol 110: 40-48.
36. Ogawa S, Menon RS, Tank DW, Kim SG, Merkle H, Ellermann JM et al (1993). Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J 64: 803-812.
37. O'Gorman RL, Mehta MA, Asherson P, Zelaya FO, Brookes KJ, Toone BK et al (2008). Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalised by stimulant treatment: a non-invasive MRI pilot study. Neuroimage 42: 36-41.
38. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001). A default mode of brain function. Proc Natl Acad Sci USA 98: 676-682.
39. Rauch A, Rainer G, Logothetis NK (2008). The effect of a serotonin-induced dissociation between spiking and perisynaptic activity on BOLD functional MRI. Proc Natl Acad Sci USA 105: 6759-6764.
40. Robbins TW, Arnsten AF (2009). The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32: 267-287.
41. Rubia K, Halari R, Christakou A, Taylor E (2009a). Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate. Philos Trans R Soc Lond B Biol Sci 364: 1919-1931.
42. Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E (2009b). Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a rewarded continuous performance task. Neuropharmacology 57: 640-652.
43. Rubia K, Halari R, Cubillo A, Smith AB, Mohammad AM, Brammer M et al (2011a). Methylphenidate normalizes frontostriatal underactivation during interference inhibition in medication-naive boys with attention-deficit hyperactivity disorder. Neuropsychopharmacol 36: 1575-1586.
44. Rubia K, Halari R, Mohammad AM, Taylor E, Brammer M (2011b). Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder. Biol Psychiatry 70: 255-262.
45. Schweitzer JB, Lee DO, Hanford RB, Tagamets MA, Hoffman JM, Grafton ST et al (2003). A positron emission tomography study of methylphenidate in adults with ADHD: alterations in resting blood flow and predicting treatment response. Neuropsychopharmacol 28: 967-973.
46. Sheridan MA, Hinshaw S, D'Esposito M (2010). Stimulant medication and prefrontal functional connectivity during working memory in ADHD: a preliminary report. J Atten Disord 14: 69-78.
47. Song XW, Dong ZY, Long XY, Li SF, Zuo XN, Zhu CZ et al (2011). REST: a toolkit for resting-state functional magnetic resonance imaging data processing. PLoS One 6: 25031.
48. Tian L, Jiang T, Liang M, Zang Y, He Y, Sui M et al (2008). Enhanced resting-state brain activities in ADHD patients: a fMRI study. Brain Dev 30: 342-348.
49. Tian L, Ren J, Zang Y (2012). Regional homogeneity of resting state fMRI signals predicts Stop signal task performance. Neuroimage 60: 539-544.
50. Vaidya CJ, Austin G, Kirkorian G, Ridlehuber HW, Desmond JE, Glover GH et al (1998). Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci USA 95: 14494-14499.
51. Volkow ND, Wang GJ, Fowler JS, Thanos PP, Logan J, Gatley SJ et al (2002). Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse 46: 79-82.
52. Wang L, Zhu C, He Y, Zang Y, Cao Q, Zhang H et al (2009). Altered small-world brain functional networks in children with attention-deficit/ hyperactivity disorder. Hum Brain Mapp 30: 638-649.
53. Zang Y, Jiang T, Lu Y, He Y, Tian L (2004). Regional homogeneity approach to fMRI data analysis. Neuroimage 22: 394-400.
54. Zang YF, He Y, Zhu CZ, Cao QJ, Sui MQ, Liang M et al (2007). Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain Dev 29: 83-91.
55. Zhong Y, Lu G, Zhang Z, Jiao Q, Li K, Liu Y (2011). Altered regional synchronization in epileptic patients with generalized tonic-clonic seizures. Epilepsy Res 97: 83-91.